Szechtman H, Talangbayan H, Canaran G, Dai H, Eilam D
Department of Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.
Psychopharmacology (Berl). 1994 Jun;115(1-2):95-104. doi: 10.1007/BF02244757.
The study characterizes the process of sensitization induced by intermittent administrations of quinpirole (0.5 mg/kg) in rats in a large open field. Sensitization was found to be self-limiting, with all measures of behavior reaching a plateau after the tenth twice-weekly injection. Kinetics of sensitization were a simple hyperbolic function of the number of drug injections for some measures (speed of locomotion, length of locomotor bouts) but showed positive co-operativity for others (distance travelled, duration of locomotion, frequency of stops, route stereotypy), suggesting potentiation of the effect by preceding injections. The pace of sensitization varied for different behaviors: locomotor speed changed fastest in the early portion of chronic treatment; stereotypy of route changed primarily during the late phase; mouthing did not sensitize. Sensitization evolved by a cascade of changes that included: advancing the onset of locomotor activation; prolonging the duration of locomotion; establishing new maxima of observable responses; altering the mode of locomotion; raising speed, rate and length of locomotor bouts; and increasing stereotypy of travel. These observations do not substantiate the prediction that development of behavioral sensitization is associated with emergence of disorganized activity and/or fractionation of response chains. Instead, it is proposed that development of sensitization may represent a build-up and strengthening of performance, reflecting enhanced central control of energy expenditure stimulated by repeated injections of quinpirole. Furthermore, it is suggested that for at least one response, the maximum observable amount of locomotion, development of sensitization requires only D2 stimulation, independent of D1 tone.
该研究描述了在大鼠大旷场中,间歇性给予喹吡罗(0.5毫克/千克)诱导致敏的过程。发现致敏是自我限制的,在每周两次的第十次注射后,所有行为指标均达到平稳状态。对于某些指标(运动速度、运动发作时长),致敏动力学是药物注射次数的简单双曲线函数,但对其他指标(行进距离、运动持续时间、停顿频率、路线刻板行为)则表现出正协同性,表明先前的注射增强了效果。不同行为的致敏速度各不相同:慢性治疗早期运动速度变化最快;路线刻板行为主要在后期发生变化;啃咬未出现致敏。致敏通过一系列变化演变而来,包括:提前运动激活的起始时间;延长运动持续时间;建立可观察到的反应的新最大值;改变运动模式;提高运动发作的速度、速率和时长;以及增加行进的刻板行为。这些观察结果并未证实行为致敏的发展与无组织活动的出现和/或反应链的分裂有关这一预测。相反,有人提出致敏的发展可能代表着行为表现的积累和强化,反映了喹吡罗重复注射刺激下中枢对能量消耗控制的增强。此外,有人认为对于至少一种反应,即最大可观察到的运动量,致敏的发展仅需要D2刺激,与D1张力无关。